Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.

Cytometry - 1 Jun 1995

Tsurusawa M, Fujimoto T

Abstract excerpt

To elucidate the relationship between the level of cellular Ki67-reactive antigen and cell proliferation, the effects of 12-O-tetra-decanoylphorbol 13-acetate (TPA) on Ki67 expression, cell cycle progression, and surface phenotypes of human T-lymphoblastic leukemia Molt-4 cells were investigated by multiparameter flow cytometry. The Ki67 antigen is constitutionally expressed in almost all untreated exponentially...

Topics

Antigens, CD
Cell Cycle
Cell Differentiation
Cell Division
Flow Cytometry
G1 Phase
G2 Phase
Humans
Ki-67 Antigen
Kinetics
Leukemia
Neoplasm Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Nuclear Proteins

Phenotype

Tetradecanoylphorbol Acetate

Tumor Cells, Cultured

Source

Identifiers

PMID: 7664625
DOI: 10.1002/cyto.990200207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-7664625-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.PMID 7664625Read ↗

Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression LevelsSemantic proximity Read ↗

The proliferative activity of B-chronic lymphocytic leukaemia lymphocytes prior to and after stimulation with TPA and PHA.Semantic proximity Read ↗

CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycleSemantic proximity Read ↗

Quantitative analysis of CD5 antigen modulation by 12-O-tetradecanoylphorbol-13-acetate in T-lymphoblastic leukemia cells: individual response patterns and their relationships with both maturation and protein kinase C content.Semantic proximity Read ↗

T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules.Semantic proximity Read ↗

Ki-67 contributes to normal cell cycle progression and inactive X heterochromatin in p21 checkpoint-proficient human cellsSemantic proximity Read ↗

Flow cytometric analysis of live cell proliferation and phenotype in populations with low viability.Semantic proximity Read ↗

Cell Cycle Arrest during Measles Virus Infection: a G0-Like Block Leads to Suppression of Retinoblastoma Protein ExpressionSemantic proximity Read ↗

Expression of intermediate filament proteins in TPA-induced MPC-11 and HL-60 cells.Semantic proximity Read ↗

p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure.Semantic proximity Read ↗

Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest.Semantic proximity Read ↗

The expression of Ki‐67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.